Multi-MeMo (“Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia”) is a European funded project that focuses on brain health in older people, overall, and tailored, multidomain interventions (i.e., targeting multiple risk factors simultaneously) for the risk-reduction of cognitive impairment and dementia, in particular. On 14 May, the first online meeting of the Multi-MeMo Advisory Board took place. The Advisory Board is composed of members of the public, with and without cognitive impairment, from seven European countries. Nine of the 13 members of the Advisory Board participated in the meeting. They discussed two main topics related to multidomain interventions: 1) the intensity of multidomain interventions, and 2) the adherence of participants to the interventions.
The meeting was facilitated by Ana Diaz (Alzheimer Europe) and the group discussions were co-facilitated by Mariagnese Barbera (University of Eastern Finland), Laura Forcano (Hospital del Mar Medical Research Institute) and Marissa Zwan (Vrije Universiteit Amsterdam). During the interactive and lively meeting, the groups examined in detail the terminology and connected concepts of various interventions’ intensity, adherence, barriers, and facilitators. They also shared personal insights into the needs of participants before, during, and after joining a multidomain intervention programme. All the feedback provided to the research partners was very valuable and relevant for carrying out and planning current and future research projects within the Multi-MeMo consortium.
For further information about Multi-MeMo, please visit the project’s website: https://www.multi-memo.eu/
Multi-MeMo is an EU Joint Programme – Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND – www.jpnd.eu: Finland, Research Council of Finland; Germany, Federal Ministry of Education and Research; Luxembourg, National Research Fund; Netherlands, The Netherlands Organisation for Health Research and Development; Slovakia, Ministry of Education, Science, Research and Sport of the Slovak Republic; Spain, National Institute of Health Carlos III.
